Enliven Therapeutics, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 45.08 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 3.30B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. Its clinical programs comprise ELVN-001, a small molecule kinase inhibitor which is in Phase 1 clinical trial to treat adults with chronic myeloid leukemia; and ELVN-002, a central nervous system (CNS) penetrant and irreversible human epidermal growth factor receptor 2 inhibitor that is in Phase 1 clinical trial for the treatment of non-small cell lung cancer (NSCLC) and other HER2 mutant tumors. The company was founded in 2019 and is headquartered in Boulder, Colorado.
Details
| Name | Enliven Therapeutics, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 67 |
| Founded | 2016 |
| Ipo Date | 2020-03-12 |
| Ceo | Richard Fair |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 16.00 |
| Isin | US29337E1029 |
| Cusip | 29337E102 |
| Cik | 1672619 |
| Sic | 2834 |
Key executives
| Name | Title |
|---|---|
| Richard A. Fair M.B.A. | Chief Executive Officer, President and Director |
| Samuel S. Kintz M.B.A. | Co-Founder and Head of Pipeline |
| Benjamin Hohl | Chief Financial Officer and Head of Corporate Development |
| Dr. Helen Louise Collins M.D. | Chief Medical Officer |
| Dr. Joseph P. Lyssikatos Ph.D. | Co-Founder and Research Fellow |
| Anish Patel Pharm.D. | Co-Founder and Chief Operating Officer |
| Dr. Galya D. Blachman Esq., Ph.D. | Chief Legal Officer and Head of Business Development |
| Damiette Smit | Vice President of Clinical Development |
Contact
| Address | 6200 Lookout Road, Boulder, Colorado 80301, United States |
| Phone | 720 647 8519 |
| Website | https://www.enliventherapeutics.com |